In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • The Utility of Magnetic Resonance Fingerprinting in Differentiating Between Cerebral Gliomas and Metastases: A Pilot Study

    Final Number:

    Andrew E. Sloan MD; Alic Yu BS; Mathew Rogers; Jeffery Sunshine MD

    Study Design:
    Laboratory Investigation

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2015 Annual Meeting

    Introduction: Conventional MRI imaging is susceptible to changes in technique making interpretation subjective. Technical characteristics of the magnet and software vary even between MRI units in the same institution. MRI can often reliably distinguish tumors from other intracranial pathologies, but classification of the tumor type is typically less reliable. MR Fingerprinting (MRF) is a new approach yielding rapid, non-invasive, precisely quantifiable imaging which is, highly reproducible between platforms. . This pilot study is the first in vivo attempt to differentiate between two important intra-axial malignant brain tumor types (gliomas and metastases) using MRF.

    Methods: A total of 27 patients with newly diagnosed intra-axial brain tumors were studied: 7 metastases (METs), 6 oligodendrogliomas (OGDs) and 14 glioblastomas (GBMs) were included. Axial imaging was acquired through representative areas of tumor region and quantitative T1 and T2 maps were generated. T1 and T2 quantification of solid tumor component (ST), immediate perilesional white matter (PWM) within 1 cm from enhancing margin, and contralateral white matter (CWM) was performed using ROI analysis. Student's t-test was used for statistical analysis and comparison between various tumor regions across different tumor types was performed.

    Results: T1, T2 measurements from ST and PWM were different than those of CWM (all p-values < 0.01). Similarly solid tumor T1 and T2 values of METs were different from those of GBMs and OGDs (all p-values < 0.01). The ST region of GBMs and OGs showed a significant difference in T2 (p < 0.01). Also, there was significant difference between PWM T2 of GBMs and METS (< 0.05).

    Conclusions: MRF is able to rapidly and simultaneously measure T1 and T2 values of brain tumors and surrounding tissues. It can reliably distinguish between solid tumor types and the perilesional white matter changes surrounding brain metastasis and the two most common gliomas.

    Patient Care: If the findings from this small pilot study can be replicated in larger studies, the need for diagnostic biopsies will be markedly diminished. This may also improve response assessment in patients with brain tumors.

    Learning Objectives: By the conclusion of this session, participants should be able to: 1) Define the challenges of image analysis of tumors using conventional MRI, 2) Define MRI Fingerprinting 3) Explain the characteristic imaging findings differentiating GBM vs oligodendrogliom vs brain mets

    References: 1. Thakkar JP, Dolecek TA, Horbinski C, Ostrom QT, Lightner DD, Barnholtz-Sloan JS, Villano JL (2014) Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev 23:1985-1996. doi: 10.1158/1055-9965.EPI-14-0275 [doi] 2. Nayak L, Lee EQ, Wen PY (2012) Epidemiology of brain metastases. Curr Oncol Rep 14:48-54. doi: 10.1007/s11912-011-0203-y [doi] 3. Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan J (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol 16 Suppl 4:iv1-63. doi: 10.1093/neuonc/nou223 [doi] 4. Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, et al (2010) Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 77:655-661. doi: 10.1016/j.ijrobp.2009.08.025 [doi] 5. Giese A, Bjerkvig R, Berens ME, Westphal M (2003) Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21:1624-1636. doi: 10.1200/JCO.2003.05.063 [doi] 6. Smith C, Ironside JW (2007) Diagnosis and pathogenesis of gliomas. Current Diagnostic Pathology 13:180-192 7. Engelhorn T, Savaskan NE, Schwarz MA, Kreutzer J, Meyer EP, Hahnen E, Ganslandt O, Dorfler A, Nimsky C, Buchfelder M, et al (2009) Cellular characterization of the peritumoral edema zone in malignant brain tumors. Cancer Sci 100:1856-1862. doi: 10.1111/j.1349-7006.2009.01259.x [doi] 8. Yang G, Jones TL, Barrick TR, Howe FA (2014) Discrimination between glioblastoma multiforme and solitary metastasis using morphological features derived from the p:q tensor decomposition of diffusion tensor imaging. NMR Biomed 27:1103-1111. doi: 10.1002/nbm.3163 [doi] 9. Provenzale JM, McGraw P, Mhatre P, Guo AC, Delong D (2004) Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging. Radiology 232:451-460. doi: 10.1148/radiol.2322030959 [doi] 10. Kinoshita M, Goto T, Okita Y, Kagawa N, Kishima H, Hashimoto N, Yoshimine T (2010) Diffusion tensor-based tumor infiltration index cannot discriminate vasogenic edema from tumor-infiltrated edema. J Neurooncol 96:409-415. doi: 10.1007/s11060-009-9979-0 [doi] 11. Pavlisa G, Rados M, Pavlisa G, Pavic L, Potocki K, Mayer D (2009) The differences of water diffusion between brain tissue infiltrated by tumor and peritumoral vasogenic edema. Clin Imaging 33:96-101. doi: 10.1016/j.clinimag.2008.06.035 [doi] 12. Wang XC, Zhang H, Tan Y, Qin JB, Wu XF, Wang L, Zhang L (2014) Combined value of susceptibility-weighted and perfusion-weighted imaging in assessing who grade for brain astrocytomas. J Magn Reson Imaging 39:1569-1574 13. Halshtok Neiman O, Sadetzki S, Chetrit A, Raskin S, Yaniv G, Hoffmann C (2013) Perfusion-weighted imaging of peritumoral edema can aid in the differential diagnosis of glioblastoma mulltiforme versus brain metastasis. Isr Med Assoc J 15:103-105 14. Wagnerova D, Herynek V, Malucelli A, Dezortova M, Vymazal J, Urgosik D, Syrucek M, Jiru F, Skoch A, Bartos R, et al (2012) Quantitative MR imaging and spectroscopy of brain tumours: a step forward? Eur Radiol 22:2307-2318. doi: 10.1007/s00330-012-2502-6 [doi] 15. Lee EJ, Ahn KJ, Lee EK, Lee YS, Kim DB (2013) Potential role of advanced MRI techniques for the peritumoural region in differentiating glioblastoma multiforme and solitary metastatic lesions. Clin Radiol 68:e689-97. doi: 10.1016/j.crad.2013.06.021 [doi] 16. Ma D, Gulani V, Seiberlich N, Liu K, Sunshine JL, Duerk JL, Griswold MA (2013) Magnetic resonance fingerprinting. Nature 495:187-192. doi: 10.1038/nature11971 [doi] 17. Deoni SC (2010) Quantitative relaxometry of the brain. Top Magn Reson Imaging 21:101-113. doi: 10.1097/RMR.0b013e31821e56d8 [doi] 18. Opstad KS, Murphy MM, Wilkins PR, Bell BA, Griffiths JR, Howe FA (2004) Differentiation of metastases from high-grade gliomas using short echo time 1H spectroscopy. Journal of Magnetic Resonance Imaging 20:187-192 19. Crisi G, Orsingher L, Filice S (2013) Lipid and macromolecules quantitation in differentiating glioblastoma from solitary metastasis: a short-echo time single-voxel magnetic resonance spectroscopy study at 3 T. J Comput Assist Tomogr 37:265-271. doi: 10.1097/RCT.0b013e318282d2ba [doi] 20. Ma L, Song ZJ (2013) Differentiation between low-grade and high-grade glioma using combined diffusion tensor imaging metrics. Clin Neurol Neurosurg 115:2489-2495. doi: 10.1016/j.clineuro.2013.10.003 [doi] 21. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev 15:1311-1333. doi: 10.1101/gad.891601 [doi] 22. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109 23. Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ (1987) Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66:865-874. doi: 10.3171/jns.1987.66.6.0865 [doi] 24. Palfi S, Swanson KR, De Bouard S, Chretien F, Oliveira R, Gherardi RK, Kros JM, Peschanski M, Christov C (2004) Correlation of in vitro infiltration with glioma histological type in organotypic brain slices. Br J Cancer 91:745-752. doi: 10.1038/sj.bjc.6602048 [doi] 25. Deng Z, Yan Y, Zhong D, Yang G, Tang W, Lu F, Xie B, Liu B (2010) Quantitative analysis of glioma cell invasion by diffusion tensor imaging. J Clin Neurosci 17:1530-1536. doi: 10.1016/j.jocn.2010.03.060 [doi] 26. Min ZG, Niu C, Rana N, Ji HM, Zhang M (2013) Differentiation of pure vasogenic edema and tumor-infiltrated edema in patients with peritumoral edema by analyzing the relationship of axial and radial diffusivities on 3.0T MRI. Clin Neurol Neurosurg 115:1366-1370. doi: 10.1016/j.clineuro.2012.12.031 [doi] 27. Wang W, Steward CE, Desmond PM (2009) Diffusion tensor imaging in glioblastoma multiforme and brain metastases: the role of p, q, L, and fractional anisotropy. AJNR Am J Neuroradiol 30:203-208. doi: 10.3174/ajnr.A1303 [doi] 28. Nakai K, Nawashiro H, Shima K, Kaji T (2013) An Analysis of T2 Mapping on Brain Tumors. In: Anonymous Brain Edema XVSpringer, pp 195-199 29. Price S, Gillard J (2014) Imaging biomarkers of brain tumour margin and tumour invasion. 30. Damadian R (1971) Tumor detection by nuclear magnetic resonance. Science 171:1151-1153 31. Araki T, Inouye T, Suzuki H, Machida T, Iio M (1984) Magnetic resonance imaging of brain tumors: measurement of T1. Work in progress. Radiology 150:95-98. doi: 10.1148/radiology.150.1.6689793 [doi] 32. Komiyama M, Yagura H, Baba M, Yasui T, Hakuba A, Nishimura S, Inoue Y (1987) MR imaging: possibility of tissue characterization of brain tumors using T1 and T2 values. AJNR Am J Neuroradiol 8:65-70 33. Just M, Thelen M (1988) Tissue characterization with T1, T2, and proton density values: results in 160 patients with brain tumors. Radiology 169:779-785. doi: 10.1148/radiology.169.3.3187000 [doi] 34. Kjaer L, Thomsen C, Gjerris F, Mosdal B, Henriksen O (1991) Tissue characterization of intracranial tumors by MR imaging. In vivo evaluation of T1- and T2-relaxation behavior at 1.5 T. Acta Radiol 32:498-504 35. Newman S, Haughton V, Yetkin Z, Breger R, Czervionke L, Williams A, Ho K, Papke R, Rimm A, Fischer M (1993) T1, T2 and proton density measurements in the grading of cerebral gliomas. Eur Radiol 3:49-52 36. Jiang Y, Ma D, Seiberlich N, Gulani V, Griswold MA (2014) MR fingerprinting using fast imaging with steady state precession (FISP) with spiral readout. Magn Reson Med . doi: 10.1002/mrm.25559 [doi]

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy